tiprankstipranks
CNS Pharmaceuticals (CNSP)
NASDAQ:CNSP
US Market
CNSP
CNS Pharmaceuticals
RESEARCH TOOLSreports
Want to see CNSP full AI Analyst Report?

CNS Pharmaceuticals (CNSP) Financial Statements

1,096 Followers

CNS Pharmaceuticals Financial Overview

CNS Pharmaceuticals's market cap is currently $6.36M. The company's EPS TTM is $-41.26; its P/E ratio is -0.10; CNS Pharmaceuticals is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-5.37. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -3.31K$ -4.13K$ -11.76K$ -13.07K
Operating Income$ -15.99M$ -14.90M$ -18.87M$ -14.93M$ -14.49M
EBITDA$ -15.83M$ -14.84M$ -18.86M$ -15.26M$ -14.47M
Net Income$ -15.85M$ -14.86M$ -18.85M$ -15.27M$ -14.50M
Balance Sheet
Cash & Short-Term Investments$ 7.20M$ 6.46M$ 548.72K$ 10.06M$ 5.00M
Total Assets$ 8.62M$ 8.70M$ 1.70M$ 13.05M$ 8.76M
Total Debt$ 328.57K$ 326.07K$ 300.81K$ 409.97K$ 387.79K
Net Debt$ -6.87M$ -6.14M$ -247.91K$ -9.65M$ -4.62M
Total Liabilities$ 4.10M$ 2.52M$ 6.13M$ 4.92M$ 2.14M
Stockholders' Equity$ 4.52M$ 6.18M$ -4.43M$ 8.13M$ 6.62M
Cash Flow
Free Cash Flow$ -13.83M$ -17.12M$ -14.14M$ -10.56M$ -13.54M
Operating Cash Flow$ -13.81M$ -17.11M$ -14.14M$ -10.56M$ -13.54M
Investing Cash Flow$ -18.18K$ -4.19K$ -3.90K$ -4.42K$ -5.75K
Financing Cash Flow$ 14.57M$ 23.03M$ 4.64M$ 15.61M$ 4.51M
Currency in USD

CNS Pharmaceuticals Earnings and Revenue History

Income Statement >

CNS Pharmaceuticals Debt to Assets

Balance Sheet >

CNS Pharmaceuticals Cash Flow

Cash Flow >

CNS Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >